Search

The article provides an update regarding atopic eczema research as of 2018, and it mentions the Global Resource of EczemA Trials (GREAT) database, the Softened Water for Eczema Prevention Pilot Trial, and an Eczema Priority Setting Partnership. The treatment of eczema is examined, along with research studies such as the Bath Additives for the Treatment of Childhood Eczema trial, Choice of Moisturiser in Eczema Treatment project, and ChildRen with the Eczema Antibiotic Management study.

Managing atopic eczema and other dry and itchy skin conditions is a skill required in all nursing specialties. Nurses need to assess and address their patients' skin-care needs. Atopic eczema and all dry and itchy skin conditions require emollient therapy to restore the skin barrier. Nurses are ideally placed to educate patients in the importance of emollient therapy and provide practical information on the individual selection of bath additives, soap substitutes and moisturizers, as well as education on application and self-management. Nurse prescribers will benefit from understanding specific individual patient needs and individual emollient properties to enable them to make informed prescribing decisions and foster patient choice in selecting the best emollient therapy for the individual. This will restore the skin barrier function, reduce itch and suit the patient. [ABSTRACT FROM AUTHOR]

Breakdown of the skin barrier is the first event in the development of atopic eczema (atopic dermatitis). Research over the past five years has indicated that this arises as a result of the interaction of environmental agents such as soap and other detergents with the products of changes in several genes. These genetic changes predispose to the breakdown of the skin barrier, which allows the penetration of allergens, triggering a flare of atopic eczema. This new understanding of how breakdown of the skin barrier is the first event in the development of atopic eczema provides a rationale for a renaissance in the use of a complete emollient therapy regimen in atopic eczema and related skin barrier breakdown diseases, such as asteatotic eczema and irritant contact dermatitis. [ABSTRACT FROM AUTHOR]